AGC
Aspen Grove Capital’s Novo Nordisk NVO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $203K | Sell |
2,944
-1,279
| -30% | -$88.3K | 0.03% | 222 |
|
|
2025
Q1 | $298K | Sell |
4,223
-119
| -3% | -$8.39K | 0.06% | 164 |
|
|
2024
Q4 | $373K | Buy |
4,342
+49
| +1% | +$4.22K | 0.08% | 125 |
|
|
2024
Q3 | $511K | Sell |
4,293
-1
| -0% | -$119 | 0.11% | 97 |
|
|
2024
Q2 | $613K | Sell |
4,294
-214
| -5% | -$30.5K | 0.14% | 84 |
|
|
2024
Q1 | $583K | Hold |
4,508
| – | – | 0.16% | 84 |
|
|
2023
Q4 | $466K | Buy |
4,508
+360
| +9% | +$37.2K | 0.14% | 88 |
|
|
2023
Q3 | $377K | Buy |
4,148
+2,105
| +103% | +$191K | 0.14% | 98 |
|
|
2023
Q2 | $331K | Buy |
2,043
+267
| +15% | +$43.2K | 0.11% | 137 |
|
|
2023
Q1 | $284K | Sell |
1,776
-1,262
| -42% | -$202K | 0.12% | 116 |
|
|
2022
Q4 | $411K | Buy |
+3,038
| New | +$411K | 0.19% | 90 |
|